Pharmacokinetics of Newer Drugs in Patients with Renal Impairment (Part II)
- 1 May 1991
- journal article
- clinical trial
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 20 (5), 389-410
- https://doi.org/10.2165/00003088-199120050-00004
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Clinical Pharmacokinetics of the Newer ACE InhibitorsClinical Pharmacokinetics, 1990
- The Influence of Renal Function on Clinical Pharmacokinetics of MoxonidineClinical Pharmacokinetics, 1988
- Multiple-Dose Pharmacokinetics of Nilvadipine in Healthy VolunteersThe Journal of Clinical Pharmacology, 1988
- Clinical Pharmacokinetics of EncainideClinical Pharmacokinetics, 1988
- Clinical Pharmacokinetics of UrapidilClinical Pharmacokinetics, 1988
- Pharmacokinetics of lisinopril in hypertensive patients with normal and impaired renal functionEuropean Journal of Clinical Pharmacology, 1988
- Pharmacokinetics of Moxonidine After Single and Repeated Daily Doses in Healthy VolunteersThe Journal of Clinical Pharmacology, 1987
- Pharmacokinetics of Cibenzoline in Patients With Renal ImpairmentThe Journal of Clinical Pharmacology, 1985
- Clinical Pharmacokinetics of the Newer Antiarrhythmic AgentsClinical Pharmacokinetics, 1984
- Pharmacokinetics of Lorcainide in ManClinical Pharmacokinetics, 1978